Search images on Google      Product Monograph

Active Ingredients:

• cangrelor (cangrelor tetrasodium), 50 MG/VIAL

DIN: 02534622

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS

Schedule: Prescription

Company: CHIESI FARMACEUTICI S.P.A.

ATC:

• B01 - ANTITHROMBOTIC AGENTS (ATC, WHO, Wiki)
• B01A - ANTITHROMBOTIC AGENTS (ATC, WHO)
• B01AC - Platelet aggregation inhibitors excl. heparin (ATC, WHO)
• B01AC25 - CANGRELOR (WHO)

Pharmaceutical standard: MFR

 

External Links for Kengrexal:

Search on Google

• Kengrexal side effects
• Kengrexal dosage
• cangrelor side effects
• cangrelor dosage